Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, α1‐adrenoceptor and benzothiazepine binding site at the calcium channel

British Journal of Pharmacology

Volumn 106, Issue 2, 1992, Pages 387-394

  Ivorra, M Dolores ^a   Lugnier, Claire ^b   Schott, Christa ^b   Catret, Maria ^a   Noguera, M Antonia ^a   Anselmi, Elsa ^a   D'Ocon, Pilar ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Calcium antagonists; glaucine; phosphodiesterase inhibitors; rat aorta; 1 adrenoceptor blocking agents

Indexed keywords

ACETYLCHOLINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BENZOTHIAZEPINE DERIVATIVE; CAFFEINE; CALCIUM ANTAGONIST; CALCIUM CHANNEL; CYCLIC AMP; CYCLIC GMP; DILTIAZEM; GLAUCINE; ISOENZYME; NIFEDIPINE; NITRENDIPINE; NORADRENALIN; PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE INHIBITOR; POTASSIUM CHLORIDE; PRAZOSIN; RADIOLIGAND;

ANIMAL TISSUE; AORTA; ARTICLE; BINDING SITE; BRAIN CORTEX; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMAL; AORTA, THORACIC; APORPHINES; BINDING, COMPETITIVE; CALCIUM CHANNELS; CATTLE; IN VITRO; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; PHOSPHODIESTERASE INHIBITORS; PRAZOSIN; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA;

EID: 0026607223     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1992.tb14345.x     Document Type: Article

References (44)

1. Effects of selective inhibition on cyclic nucleotide phosphodiesterase of rabbit aorta
2. Selective inhibition of calcium entry induced by benzylisoquinolines in smooth muscle
3. Multiple isozymes of cyclic nucleotide phosphodiesterase
4. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors
5. Mechanisms of action of transmitters and other substances on smooth muscle
6. 50) of an enzymatic reaction
7. Relationship between phosphatidylinositol turnover and Ca mobilization induced by α 1‐adrenoceptor stimulation in the rat aorta
8. Norstephalagine et atherospermidine, deux aporphines dArtabotrys maingayi relaxantes du muscle lisse
9. Spasmolitic activity of cinnamedrine and papaverine in isolated rat uterine muscle
10. 2‐adrenoceptors in several blood vessels isolated from the rabbit
11. Inhibition of calcium entry induced by cularines and isocrasifoline in uterine smooth muscle
12. Antioquine: a new bisbenzylisoquinoline alkaloid with calcium antagonist activity
13. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
14. Isolation and characterization of bovine cardiac muscle cGMP‐inhibited phosphodiesterase: a receptor for new cardiotonic drug
15. Differences and similarities in the noradrenale‐ and caffeine‐induced mechanical responses in the rabbit mesenteric artery
16. Characterization of membrane‐bound cyclic nucleotide phosphodiesterases from bovine aortic smooth muscle
17. Ca‐localization and sensitivity in vascular smooth muscle
18. Caffeine‐induced contraction in vascular smooth muscle
19. In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides
20. Interaction of tetrandrine with slowly inactivating calcium channels
21. Subcellular distribution of high‐affinity type IV cyclic AMP phosphodiesterase activity in rabbit ventricular myocardium relations to the effects of cardiotonic drugs
22. Differential sensitivity to cardiotonic drugs of cyclic AMP phosphodiesterases isolated from canine ventricular and sinoatrial‐enriched tissues
23. Endothelium‐dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors
24. Inhibition of cyclic‐3′, 5‐nucleotide phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs
25. Diproteverine (BRL 40015): a new type of calcium antagonist with potential antianginal properties
26. Identification of the cyclic GMP‐inhibited low Km cyclic AMP phosphodiesterase in rat aortic smooth muscle
27. Cyclic nucleotide phosphodiesterase inhibition and vascular smooth muscle relaxation
28. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta
29. Selective inhibition of one of the cyclic AMP phosphodiesterases from rat brain by the neurotropic compound rolipram
30. Different and common intracellular calcium‐stores mobilized by noradrenaline and caffeine in vascular smooth muscle
31. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea‐pig cardiac ventricle
32. Effects of papaverine on the frequency‐force relationship in guinea‐pig left atria
33. Multiple effects of caffeine on contractions and cytosolic free Ca levels in vascular smooth muscle of rat aorta
34. 3H]‐nitrendipine binding sites
35. 2+ current in guinea‐pig heart
36. Stereoselective blockade of α‐adrencorptors by berbine derivatives
37. Rolipram, a stereospecific inhibitor of calmodulin‐independent phosphodiesterase, causes β‐adrenoceptor subsensitivity in rat cerebral cortex
38. General properties for multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system
39. The low Km‐phosphodiesterase inhibitor denbufylline enhances neuronal excitability in guinea pig hippocampus in vitro
40. Ca‐channels ligands: structure‐function relationships of the 1,4‐dihydropyridines
41. Dihydro and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart
42. A new generation of phosphodiesterase inhibition: multiple molecular forms of phosphodiesterase and the potential for drug selectivity
43. Subclasses of cyclic AMP‐specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility
44. Cyclic nucleotide phosphodiesterase activity of pig coronary arteries